What to Know About New Covid Vaccines for Fall 2026
The FDA approved four updated Covid-19 vaccines on Thursday to address the autumn increase in respiratory illnesses. These include mRNA options from Moderna and the COMIRNATY vaccine from Pfizer and BioNTech. The Pfizer and BioNTech version targets the XFG variant for high-risk groups. Authorizations specifically include people aged 65 and older. These shots should reach hospitals and pharmacies within days. Current reports indicate Covid-19 is rising again in some regions, such as the Bay Area, as students return to school.
What changed
Recent reports indicate Covid-19 is spreading again in the Bay Area as children return to school.
Live updates
-
FDA Approves Updated Covid-19 Vaccines for Fall 2026
The FDA approved four updated Covid-19 vaccines on Thursday to address the autumn increase in respiratory illnesses. These include mRNA options from Moderna and the COMIRNATY vaccine from Pfizer and BioNTech. The Pfizer and BioNTech version targets the XFG variant for high-risk groups. Authorizations specifically include people aged 65 and older. These shots should reach hospitals and pharmacies within days. Current reports indicate Covid-19 is rising again in some regions, such as the Bay Area, as students return to school.
Why it matters
Health officials release updated vaccines annually to combat evolving variants and waning immunity. These approvals target specific strains to maintain protection during the typical winter surge.
What is confirmed
- The FDA approved four updated Covid-19 vaccines on Thursday.
- Approved vaccines include mRNA options from Moderna and the COMIRNATY vaccine from Pfizer and BioNTech.
- The Pfizer and BioNTech vaccine targets the XFG variant for high-risk individuals.
- New authorizations specifically include individuals aged 65 and older.
Still unconfirmed
- Covid-19 is on the rise in the Bay Area.
What to watch next
- Confirmation of vaccine arrival at pharmacies and hospitals.
- Data on the effectiveness of the XFG-targeted vaccine against current strains.
confidence 100%Sources used for this update (6)
- CIDRAP — FDA approves new COVID vaccines
- kare11.com — What to know about the COVID and flu vaccines for 2026
- jen.jiji.com — MotoGp, today Aragon race: schedule, starting grid and where to watch the Grand Prix
- www.bangordailynews.com — Maine waited years for a Lyme vaccine. RFK hobbled the panel needed for a smooth rollout
- www.record-bee.com — COVID is spreading again. Here’s who should take precautions
- www.ualrpublicradio.org — Opinion: Remembering Dolly Parton
-
FDA Approves Four Updated Covid-19 Vaccines for Fall 2026
The FDA approved four updated Covid-19 vaccines on Thursday to prepare for the autumn spike in respiratory diseases. These shots include mRNA options from Moderna and the COMIRNATY vaccine from Pfizer and BioNTech. The updated versions are expected to arrive at pharmacies and hospitals within days. While the Pfizer and BioNTech shot targets the XFG variant for high-risk people, the new approvals specifically include authorizations for individuals aged 65 and older.
Why it matters
Health officials are pushing these updates as Covid-19 cases rise in regions like the Bay Area. Older adults, young children, and immunocompromised individuals remain the most vulnerable populations. These seasonal updates aim to combat evolving variants during the period of highest infection risk.
What is confirmed
- The FDA approved updated Covid-19 vaccines.
- The approved vaccines include mRNA options from Moderna and the COMIRNATY vaccine from Pfizer and BioNTech.
Still unconfirmed
- The vaccines are expected to roll out at hospitals and pharmacies in just days.
- Four updated covid-19 shots earned approval from the Food and Drug Administration Thursday.
- The shots were approved for those age 65 and older.
What to watch next
- Confirmation of the exact date vaccines become available at pharmacies
- FDA guidance on eligibility for individuals under age 65
confidence 90%Sources used for this update (6)
- CNN — FDA approves updated Covid-19 vaccines
- upi.com — FDA approves latest version of Pfizer's COVID-19 mRNA vaccine
- ABC News - Breaking News, Latest News and Videos — FDA approves updated COVID vaccines. Here's what you need to know
- www.yahoo.com — The FDA just approved this year’s Covid vaccines - here’s what you need to know about the shots
- www.thewrap.com — The Top 21 New Movies Streaming Now
- TribLIVE.com — 5 things to know about the newly approved covid-19 vaccines
-
FDA Approves Updated COVID-19 Vaccines for 2026-2027 Season
The U.S. FDA has approved updated COVID-19 vaccines for the 2026-2027 season to combat rising cases. These updated shots include mRNA options from Moderna and a COMIRNATY vaccine from Pfizer and BioNTech. The Pfizer and BioNTech version specifically targets the XFG variant for high-risk individuals. Health officials recommend these updates as COVID-19 spreads again in certain regions, such as the Bay Area, where older adults, young children, and immunocompromised people face the highest risk.
Why it matters
Vaccine updates are released seasonally to address evolving viral variants. The current approval focuses on the XFG-adapted mRNA formula to maintain protection as case numbers climb.
What is confirmed
- The FDA approved updated COVID-19 vaccines for the 2026-2027 season.
- Moderna received FDA approval for its updated 2026-2027 vaccines.
- Pfizer and BioNTech received FDA approval in August 2026 for an updated COMIRNATY vaccine targeting the XFG variant for high-risk individuals.
- The 2026-2027 season includes an XFG-adapted mRNA vaccine.
Still unconfirmed
- COVID-19 cases are currently rising in the Bay Area.
What to watch next
- Distribution timelines for the XFG-adapted vaccines
- Public health guidance on eligibility for the general population versus high-risk groups
confidence 100%Sources used for this update (10)
- The New York Times — What to Know About New Covid Vaccines for Fall 2026
- The Washington Post — FDA just approved updated covid shots. Here’s what to know as cases rise.
- Pharmacy Times — FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
- New Castle News — Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
- U.S. News & World Report — US FDA Approves Updated COVID Vaccines for 2026-27 Season
- The Hill — FDA approves new COVID-19 shots
- finance.yahoo.com — The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why
- www.dailypress.com — COVID is spreading again in the Bay Area. Here’s who should take precautions
- www.kqed.org — Who Should Get an Mpox Vaccine Before San Francisco’s Fall Party Season Begins?
- www.prevention.com — Should I Get a Measles Booster? Infectious Disease Doctors Explain